Maximus, Inc. (NYSE:MMS) is Van Berkom & Associates Inc.’s 9th Largest Position

Van Berkom & Associates Inc. lifted its stake in Maximus, Inc. (NYSE:MMS) by 8.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,256,418 shares of the health services provider’s stock after purchasing an additional 98,264 shares during the quarter. Maximus comprises about 2.8% of Van Berkom & Associates Inc.’s holdings, making the stock its 9th largest holding. Van Berkom & Associates Inc.’s holdings in Maximus were worth $93,792,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after buying an additional 158 shares in the last quarter. Eastern Bank purchased a new stake in shares of Maximus in the fourth quarter valued at about $29,000. V Square Quantitative Management LLC increased its position in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd acquired a new stake in Maximus during the fourth quarter worth about $54,000. Finally, Quarry LP raised its stake in Maximus by 48.0% during the third quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock worth $95,000 after purchasing an additional 330 shares during the period. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 2,208 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now directly owns 6,567 shares in the company, valued at $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Insiders have bought 7,063 shares of company stock worth $502,017 over the last ninety days. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on MMS shares. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd.

Maximus Stock Down 2.2 %

Shares of MMS opened at $66.80 on Friday. The company’s 50-day moving average price is $73.87 and its 200 day moving average price is $81.87. Maximus, Inc. has a 12-month low of $65.79 and a 12-month high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm has a market cap of $3.78 billion, a P/E ratio of 14.36 and a beta of 0.72.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, sell-side analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date is Friday, February 14th. Maximus’s payout ratio is 25.81%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.